Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04218682 · ClinicalTrials.gov registry record · NA
Shadows Edge Mobile Developing Resilience in Adolescent and Young Adult Cancer Survivors
A NA study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 177
- Enrollment target
NCT04218682 is a NA study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 177 participants.
The verdict
NCT04218682, a NA study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 177 participants
- Enrollment target
Study Summary
This study evaluates the efficacy of an interactive mobile game, Shadow's Edge, on enhancing resilience, promoting identity development, and decreasing somatic symptoms among adolescent and young adult survivors of cancer.
Interventions
- BEHAVIORAL Shadow's Edge Mobile Application Gameplay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2018-12-10 |
| Est. Completion | 2020-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04218682
The ClinicalTrials.gov registry entry for NCT04218682 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Shadow's Edge Mobile Application Gameplay is the first listed.
NCT04218682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04218682 about?
NCT04218682 is a clinical study titled "Shadows Edge Mobile Developing Resilience in Adolescent and Young Adult Cancer Survivors". This study evaluates the efficacy of an interactive mobile game, Shadow's Edge, on enhancing resilience, promoting identity development, and decreasing somatic symptoms among adolescent and young adult survivors of cancer.
What is the current status of trial NCT04218682?
This trial is currently completed. It is a NA study. The enrollment target is 177 participants. The study started on 2018-12-10. Estimated completion is 2020-04-01.
What interventions are being tested in trial NCT04218682?
The interventions under investigation include: Shadow's Edge Mobile Application Gameplay (BEHAVIORAL).
Who is sponsoring clinical trial NCT04218682?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.